Data4Industry-X Orchestrates Federated Data Spaces with Data Governance Standards for Industry
31.3.2025 08:30:00 CEST | Business Wire | Press Release
Data4Industry-X, the trusted industry data space solution, builds its momentum by delivering the most comprehensive and flexible solution to foster seamless, secure and useful data impatriation of all shopfloors across the world. Actively contributing to the Manufacturing-X initiative, Data4Industry-X is now initiating interoperability with other Data Spaces, such as the one powered by the LNI 4.0 Association in the context of International Manufacturing-X, to promote the orchestration of federated data spaces which supports Manufacturing-X ambition to create a compelling and sustainable global industry ecosystem. This interoperability with other data spaces will be demonstrated at Hannover Messe, from March 31 to April 4, along with real use cases of enhanced end-to-end data impatriation scenarios for smooth and powerful cross-border, cross-company, cross-shop floor industrial data exchanges.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250330092260/en/
The interoperability of Data4Industry-X with other data spaces will reinforce trust between organizations in the ecosystem and bring new business opportunities to industrial organizations. Thanks to the interconnection between data spaces, industrial organizations will gain broader access to data from players from other data spaces, and be able to exchange data with new participants while benefiting from a pre-defined and pre-negotiated contractual framework, resulting from the negotiations concluded by the orchestrators of the interconnected data spaces. To support industrial organization objectives, secure and compliant data exchange has become essential to ensure trusted data transactions and collaboration across the data ecosystem.
Powered by Dawex Data Exchange technology, the Data4Industry-X delivers the most flexible and advanced data exchange solution, implementing the Gaia-Xde facto standard, using the Gaia-X Digital Clearing House compliance services, interfacing with OPC-UA protocol thanks to the Unified Data Collector solution from Prosyst, interfacing with Data Space protocol, supporting Open API formats and Asset Administration Shell data models, and integrating with decentralized connectors such as Eclipse Dataspace Components Connectors. Data4Industry-X also relies on Schneider Electric building blocks on data continuum from the IIoT box to the data space, on the CEA-List technology development towards the decentralization of data spaces, and on Valeo use cases development leveraging data using AI for the forecasting and reduction of CO2 emissions.
“Data4Industry-X has reached a new milestone by demonstrating interoperability with other data spaces and end-to-end industrial data exchanges. This momentum supports the dynamics for a strong, sustainable industry,” said Laurent Lafaye, co-CEO at Dawex. “Data4Industry-X ultimately empowers industry stakeholders of all sizes to participate in data exchange, to securely exchange, distribute and valorize industrial data, fostering a broad, resilient and sustainable industry ecosystem.”
Data4Industry-X is supported by the French government’s France 2030 initiative, the European program Next Generation and by the AIF (Alliance pour l’industrie du futur), and gathers technological & industrial expertise from Dawex, Schneider Electric, Valeo, CEA-List, and Prosyst.
Visit Data4Industry-X at Hannover Messe, on Plattform 4.0 booth on Hall 8, stand D26.
Data4Industry-X use cases showcased at Hannover Messe include Carbon Footprint Reporting, Real Time Data Impatriation from Shopfloors, and Asset Lifecycle Management.
About Dawex
https://www.dawex.com/
About Schneider Electric
www.se.com
About Valeo
https://www.valeo.com/en/
About CEA-List
https://www.cea.fr/english
About Prosyst
https://www.prosyst.fr/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250330092260/en/
Contacts
Press contact: Isabelle Joulot, Vice President Communications & Marketing, Dawex
press@dawex.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom